Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 24, 2016 08:30 ET | Source: BeyondSpring Pharmaceuticals

BeyondSpring Pharmaceuticals to Present Today at 4th Annual Cancer Biopartnering & Investment Forum in NYC

NEW YORK, Feb. 24, 2016 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies including a Phase...
February 08, 2016 08:30 ET | Source: BeyondSpring Pharmaceuticals

BeyondSpring Pharmaceuticals’ Data Indicating Plinabulin Enhances Immune Response Provides Basis for Planned Phase I/II Combination Trial in NSCLC

NEW YORK, Feb. 08, 2016 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies including a Phase...
February 03, 2016 08:30 ET | Source: BeyondSpring Pharmaceuticals

BeyondSpring Pharmaceuticals to Present at 18th Annual BIO CEO & Investor Conference

NEW YORK, Feb. 03, 2016 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies including a Phase...
January 07, 2016 08:00 ET | Source: BeyondSpring Pharmaceuticals

BeyondSpring Pharmaceuticals to Present at 8th Annual Biotech Showcase

NEW YORK, Jan. 07, 2016 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies including a Phase...
January 06, 2016 09:51 ET | Source: BeyondSpring Pharmaceuticals

BeyondSpring Pharmaceuticals and Fred Hutchinson Cancer Research Center Enter Collaboration Agreement

NEW YORK, Jan. 06, 2016 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies including a Phase...
January 05, 2016 10:32 ET | Source: BeyondSpring Pharmaceuticals

BeyondSpring Pharmaceuticals to Present Plinabulin-Immune System Interactions at AACR’s 2016 Tumor Microenvironment Special Conference

NEW YORK, Jan. 05, 2016 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies including a Phase...
December 21, 2015 16:00 ET | Source: BeyondSpring Pharmaceuticals

BeyondSpring Pharmaceuticals Granted CTA by CFDA to Initiate China Arm of Global Phase III Trial of Lead Asset Plinabulin

NEW YORK, Dec. 21, 2015 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused on the development of innovative immuno-oncology cancer therapies,...
November 17, 2015 08:00 ET | Source: BeyondSpring Pharmaceuticals

BeyondSpring Data Demonstrating Activity of Plinabulin in Kras-Mutant Tumors Presented at AACR-NCI-EORTC International Conference 2015

NEW YORK, Nov. 17, 2015 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced...
October 30, 2015 07:00 ET | Source: BeyondSpring Pharmaceuticals

BeyondSpring Announces Appointments of Dr. Ramon Mohanlal as Chief Medical Officer and Robert Dickey IV as Chief Financial Officer

NEW YORK, Oct. 30, 2015 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced...
September 15, 2015 10:19 ET | Source: BeyondSpring Pharmaceuticals

BeyondSpring Announces Positive Follow-Up Results for Phase 2 Trial of Plinabulin in Advanced NSCLC at WCLC 2015

NEW YORK, Sept. 15, 2015 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced...